Titre:
  • A phase III randomised trial assessing the activity of first-line ifosfamide-gemcitabine (IG), a non-platinum chemotherapy (CT), in patients with advanced non small cell lung cancer (NSCLC)
Auteur:Berghmans, Thierry; Lafitte, Jean-Jacques; Paesmans, Marianne; Meert, Anne-Pascale; Scherpereel, Arnaud; Leclercq, Nathalie; Sculier, Jean-Paul
Informations sur la publication:European respiratory Society Annual Congress, (Amsterdam, The Netherlands)
Statut de publication:Publié, 2011
Sujet CREF:Sciences bio-médicales et agricoles
Langue:Anglais